SX-682 clinical trials

Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer

This study is looking into a new combination of medicines, SX-682 and Apalutamide, for men with prostate cancer that has spread and is no longer responding to standard hormone therapy. We want to see if this new combination can help slow down the cancer.